How would I detect oxidation in a tirzepatide vial without sending it to Janoshik?

Conditions: oxidation · tirzepatide · Janoshik.

I have done this once and I suspect I got away with it rather than got it right.

For context: I keep records of every batch, every lot number and every result, so an answer that requires me to track something is fine.

What does a defensible version of this look like in practice?

Specifically, the common error is getting the concentration right but then misreading the syringe scale, which is why checking the barrel marking rather than your memory matters.

Do not use the same needle to pierce the stopper and to administer. The tip is blunted by the stopper, and the hub now contains a dose you are about to lose to dead space anyway.

Number of stopper piercings matters less than the gauge doing the piercing. A 30G or 31G needle through a butyl stopper leaves a track that reseals; a 21G or 18G drawing needle punches a core and can drop it into the solution.

The insulin-unit standard U-100 means 100 units per millilitre, so one unit is 0.01 mL — this is the conversion that trips up more people here than any other single piece of arithmetic.

Write the arithmetic on the vial label. It costs nothing and removes the step where you reconstruct it from memory.

In practice, the arithmetic only stops being confusing once you work it through once and see that it is straightforward.

The concentration you actually work with is label claim times content fraction divided by actual diluent volume, which is usually not the same as the nominal concentration because content is usually not 100 per cent and you rarely measure the diluent volume to 0.1 mL precision.

Worth being precise here: on filtration: a 0.22 µm syringe filter will remove particulates and organisms, and it will also adsorb a fraction of your peptide onto the membrane — with a low-binding PVDF or PES membrane the loss is typically a few per cent.

Worth noting: the concentration after reconstitution is not the same as the label claim, and most people do not account for the difference.

Do the arithmetic twice, ideally with someone else doing it independently.

Worth being precise here: this is arithmetic, so let us do the arithmetic rather than argue about it.

Worked example, because the general form is easier to trust once you have seen it once. Take a 10 mg vial and add 2 mL of diluent: the concentration is 10 ÷ 2 = 5 mg/mL. A 0.5 mg dose is 0.5 ÷ 5 = 0.1 mL. On a U-100 syringe, where 1 unit = 0.01 mL, that is 0.1 ÷ 0.01 = 10 units. Change the diluent to 1 mL and the same dose becomes 5 units — same dose, half the resolution.

Published data on syringe dead space quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more for conventional detachable-needle syringes.

The limitation is that technique reduces risk, it does not remove it, and nothing you can do outside a controlled environment makes a non-sterile preparation sterile.

If in doubt, use more diluent and accept the shorter usable window.

Rounding to the nearest whole syringe unit is usually the right error to make, but understanding which direction it is and why matters.

Room temperature before drawing is worth the ten minutes. Cold solution is more viscous, draws slower, and condensation on a cold barrel makes it harder to read the meniscus.

I would flag the obvious failure mode: people get the concentration right, get the volume right, and then read the syringe against the wrong scale.

Write the arithmetic on the vial label. It costs nothing and removes the step where you reconstruct it from memory.